NEW YORK (GenomeWeb) – Vela Diagnostics announced today that its next-generation sequencing-based Sentosa SQ HIV genotyping assay is now CE-IVD marked for in vitro diagnostic usage.The company plans to use the assay to detect HIV-1 Group M genomic mutations in protease, reverse transcriptase, and integrase regions from plasma in patients with HIV.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.